- Home
- SYBX vs AMS Comparison
SYBX vs AMS Comparison
Compare SYBX & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- AMS
- Stock Information
- Founded
- SYBX N/A
- AMS 1980
- Country
- SYBX United States
- AMS United States
- Employees
- SYBX N/A
- AMS N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- SYBX Health Care
- AMS Health Care
- Exchange
- SYBX Nasdaq
- AMS Nasdaq
- Market Cap
- SYBX 16.5M
- AMS 19.3M
- IPO Year
- SYBX N/A
- AMS N/A
- Fundamental
- Price
- SYBX $1.20
- AMS $2.80
- Analyst Decision
- SYBX
- AMS
- Analyst Count
- SYBX 0
- AMS 0
- Target Price
- SYBX N/A
- AMS N/A
- AVG Volume (30 Days)
- SYBX 6.3K
- AMS 27.6K
- Earning Date
- SYBX 03-06-2025
- AMS 05-13-2025
- Dividend Yield
- SYBX N/A
- AMS N/A
- EPS Growth
- SYBX N/A
- AMS 779.12
- EPS
- SYBX N/A
- AMS 0.61
- Revenue
- SYBX $8,000.00
- AMS $24,969,000.00
- Revenue This Year
- SYBX N/A
- AMS $27.74
- Revenue Next Year
- SYBX N/A
- AMS $17.72
- P/E Ratio
- SYBX N/A
- AMS $4.69
- Revenue Growth
- SYBX N/A
- AMS 20.83
- 52 Week Low
- SYBX $1.15
- AMS $2.64
- 52 Week High
- SYBX $1.96
- AMS $4.60
- Technical
- Relative Strength Index (RSI)
- SYBX 34.47
- AMS 45.88
- Support Level
- SYBX $1.27
- AMS $2.75
- Resistance Level
- SYBX $1.32
- AMS $2.90
- Average True Range (ATR)
- SYBX 0.05
- AMS 0.09
- MACD
- SYBX -0.01
- AMS 0.01
- Stochastic Oscillator
- SYBX 17.81
- AMS 37.50
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.